Tag: Francis Ohanyido

AstraZeneca halts COVID-19 vaccine trial for safety review

A major vaccine trial by British-Swedish drugmaker AstraZeneca was halted due to a serious adverse reaction by a participant in the trials. The company plans to have a safety review and minimise the impact on the trial timeline. Meanwhile, the World Health Organisation has started a review of the international health response strategy to the COVID-19 pandemic on Tuesday. Dr Francis Ohanyido, President of the West Africa Academy of Public Health joins CNBC Africa for more.

Nigeria seeks to improve turnaround time for COVID-19 testing & results

Nigeria’s Minister of Finance, Budget and National Planning, Zainab Ahmed, says the federal government plans to engage insurers for special products for healthcare workers.

How Nigeria plans to prevent COVID-19 outbreak in the country

Chinese health officials say data from a new study by the Chinese Centre for Disease Control and Prevention shows that the elderly and sick are more at risk. Meanwhile, Nigeria’s Center for Disease Control says intensified screening at points of entry is ongoing as means of preventing the Coronavirus outbreak in Nigeria. Dr. Francis Ohanyido, President of the West Africa Academy of Public Health joins CNBC Africa to discuss ways Nigeria can avert disease outbreaks.

DRC readies to deploy 1st ever new Ebola treatment drug

Moving a step further from the use of experimental vaccines, the Democratic Republic of Congo has started using an experimental Ebola treatment on patients, the first ever deployed against an active outbreak. Francis Ohanyido, Chair of the Board of Directors of the West African Academy of Public Health joins CNBC Africa to discuss this.
Advertisment